Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/89/55/21/89552172-8fb7-4f33-7fde-c151dbde48b0/mza_17670698278821398717.png/600x600bb.jpg
FDA Drug Safety Podcasts
U.S. Food and Drug Administration, Center for Drug Evaluation and Research
60 episodes
9 months ago
FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts
Show more...
Medicine
Government,
Health & Fitness,
Science,
Life Sciences
RSS
All content for FDA Drug Safety Podcasts is the property of U.S. Food and Drug Administration, Center for Drug Evaluation and Research and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts
Show more...
Medicine
Government,
Health & Fitness,
Science,
Life Sciences
Episodes (20/60)
FDA Drug Safety Podcasts
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
10 months ago
5 minutes

FDA Drug Safety Podcasts
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause
1 year ago
3 minutes 30 seconds

FDA Drug Safety Podcasts
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab)
1 year ago
4 minutes

FDA Drug Safety Podcasts
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
1 year ago
3 minutes 30 seconds

FDA Drug Safety Podcasts
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
1 year ago
5 minutes 5 seconds

FDA Drug Safety Podcasts
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions
2 years ago
5 minutes 30 seconds

FDA Drug Safety Podcasts
FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use
2 years ago
7 minutes 30 seconds

FDA Drug Safety Podcasts
FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)
2 years ago
4 minutes

FDA Drug Safety Podcasts
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib)
3 years ago
4 minutes

FDA Drug Safety Podcasts
FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns
3 years ago
2 minutes

FDA Drug Safety Podcasts
FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging
3 years ago
4 minutes 30 seconds

FDA Drug Safety Podcasts
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib)
3 years ago
3 minutes 30 seconds

FDA Drug Safety Podcasts
FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain
3 years ago
5 minutes 59 seconds

FDA Drug Safety Podcasts
FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury
4 years ago
4 minutes

FDA Drug Safety Podcasts
FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions
4 years ago
4 minutes

FDA Drug Safety Podcasts
FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins
4 years ago
3 minutes

FDA Drug Safety Podcasts
FDA warns that vapors from alcohol-based hand sanitizers can have side effects
4 years ago
4 minutes 29 seconds

FDA Drug Safety Podcasts
Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis
4 years ago
3 minutes

FDA Drug Safety Podcasts
Studies show increased risk of heart rhythm problems with seizure and mental health medicine lamotrigine (Lamictal) in patients with heart disease
4 years ago
3 minutes

FDA Drug Safety Podcasts
FDA warns that abuse and misuse of the OTC nasal decongestant propylhexedrine can lead to serious harm
4 years ago
3 minutes

FDA Drug Safety Podcasts
FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts